Headache Medicine Certification Examination Committee Contributors
Stephanie J. Nahas, MD, MSEd, Chair, Thomas Jefferson University/Jefferson Headache Center
Disclosures: Received honoraria for consulting from AbbVie, Amneal (ended June 2024), Axsome (ended May 2024), Bausch Health (ended July 2025), Eli Lilly (ended November 2024), Lundbeck (ended October 2023), Pfizer, and Tonix (ended November 2023). Received honoraria for work in education or publishing from American Academy of Neurology, American Headache Society, Diamond Headache Clinic Research and Educational Foundation, MedLink Neurology, Springer, WebMD/Medscape, and Wolters-Kluwer.
Teshamae S. Monteith, MD, Vice Chair, University of Miami
Disclosures: Received compensation for Advisory: Lundbeck, Axsome, Abbvie, Pfizer, and Teva. Received compensation for consulting for Merz. Received compensation from Continuum (associate editor, audio), Cephalalgia/Cephalalgia Reports (associate editor), New England Journal of Medicine Journal Watch/Clinician (deputy editor), and Neurology Minute (Deputy Editor). Unpaid positions: American Migraine Foundation (board of directors), Florida Society of Neurology (board of directors), and International Headache Society (board of directors). Research support paid to institution: role as site PI for studies led by Abbvie, Eli Lilly, Ipsen. Recipient of educational grant: from Abbvie (paid to institution); received personal fees from Medscape, Massachusetts Medical Society, American Headache Society, and American Academy of Neurology/American Academy of Neurology Institute. Unpaid co-author for publications sponsored by Abbvie, Pfizer, and Theranica.
Moises Dominguez, MD, Weill Cornell Medicine
Disclosures: Nothing to disclose.
Marshall C. Freeman, MD, Headache Wellness Center
Disclosures: Received research support as Principal Investigator: AbbVie, Biohaven, Ipsen, Kallyope, Lundbeck, and Pfizer. Received compensation as guest speaker, Southern Headache Society.
P. Christopher H. Gottschalk, MD, Yale Neurology – Headache Division
Disclosures: Received consulting compensation from Lundbeck, Abbvie, Tonix, Pfizer, and Theranica. Received scientific advisory board compensation from Impel, Satsuma, Vectura Fertin. Received compensation as associate editor, Headache (AHS journal). Received research support from Rehaler--Co-PI, device trial; Ipsen--Co-PI. Serves as immediate past president, AHDA (Alliance for Headache disorders advocacy).
Christopher B. Oakley, MD, Johns Hopkins University – Department of Child Neurology
Disclosures: Received compensation as an expert witness in a legal case involving Botox and Allergan. Received royalties for a published book on pediatric headache.
Nina Riggins, MD, Headache Centers of Excellence VA Healthcare
Disclosures: Received compensation as Advisory Board Member for NeurologyLive, Lundbeck, Amneal, and Teva. Received compensation as guest editor NeurologyLive. Non compensated, serving on the Board "Miles for Migraine." Principal investigator (PI) Eli Lilly, Theranica clinical trials. Uncompensated work as PI on Research Device from Dolor Technology and TheraSpecs. Participated in educational project, not compensated, with Pfizer.
Hossain Ansari, MD, Kaizen Brain Center
Disclosures: Received compensation for serving on Advisory Board from Lundbeck Pharmaceutical and AbbVie. Received compensation for serving on speaker’s bureau from AbbVie pharmaceutical and Scilex Holdings, Inc.
Seniha Ozudogru, MD, University of Pennsylvania
Disclosures: Nothing to disclose.
Carrie E. Robertson, MD, Mayo Clinic - Rochester
Disclosures: Received compensation as a consultant for AbbVie. Received compensation from LinPharma advisory board. Received compensation as associate editor for UpToDate. Received research support from Pfizer (current) and Lundbeck (through late 2023).